期刊文献+

用活化的单甲氧基聚乙二醇修饰L-天冬酰胺酶 被引量:6

Modification of L-Asparaginase with mPEG_2
下载PDF
导出
摘要 使用活化的单甲氧基聚乙二醇 ( m PEG2 )对 L -天冬酰胺酶进行修饰 ,修饰过程中加入底物 L-天冬酰氨保护酶的活性中心。得到的修饰酶抗体结合能力消失 ,保留酶比活力 32 .8% ,酶的常温稳定性和热稳定性均有显著提高。荧光胺法分析残余氨基数目得出酶分子的 92个自由氨基中有5 Activated methoxypolyethylene glycol (mPEG 2) was used to modify L asparaginase. During this course, L Asn, the substrate of L asparaginase, was added to protect the active center of the enzyme. The residue activity of modified enzyme is 32.8% when the affinity to antibody disappear and the stability of modified enzyme is promoted obviously. Analysis of the residue of —NH 2 by fluorescamine method shows that 51 —NH 2 of 92 —NH 2 of the enzyme are modified by the modifier.
出处 《华东理工大学学报(自然科学版)》 CAS CSCD 北大核心 2001年第6期601-604,共4页 Journal of East China University of Science and Technology
关键词 MPEG2 L-天冬酰胺酶 修饰 荧光胺法 单甲氧基聚乙二醇 抗癌药物 酶活力 mPEG 2 L asparaginase modification fluorescamine
  • 相关文献

参考文献3

二级参考文献2

  • 1曹淑桂,高等学校化学学报,1989年,10期,289页
  • 2团体著者,生化技术导论,1978年

共引文献9

同被引文献86

  • 1张新胜,祁国珍.相转移催化反应的研究IV.聚乙二醇催化机理[J].华东理工大学学报(自然科学版),1994,20(6):782-787. 被引量:5
  • 2朱珺,王松梅,沈炜明,吴自荣,刘银坤.抗肿瘤转移多聚β肽聚乙二醇化的研究[J].中国新药与临床杂志,2005,24(9):723-726. 被引量:6
  • 3韦玉军,陈建华,吴梧桐.E.coli L-天冬酰胺酶结构与功能及其纯化工艺[J].药学进展,2005,29(9):397-404. 被引量:5
  • 4公伟,薛春佳,冯军,赵文杰.单甲氧基聚乙二醇修饰L-门冬酰胺酶的研究[J].中国医药工业杂志,2007,38(5):336-339. 被引量:5
  • 5Fabry U, Korholz D, Jurgens H, et al. Anahylaxis to L - Asparaginase during treatment for acutement mediated mechanism[J]. Pediatr Res, 1985, 19(4) :400.
  • 6] Keating M J, Holmes R, Lerner S, et al. L - asparaginase and PEG asparaginase: past, present, and future [J]. Leuk Lymphoma, 1993, 10..153.
  • 7Matsushima A, Nishimura H, Ashihara Y, et al. Modifica tion of E. coli asparaginase with 2,4-bis(O-methoxy-polyeth ylene glyeol)-6-chloro-S-triazine disapperance of binding abil ity towards anti-serum and retention of enzymic activity[J]. Chem Letter, 1980, 9(7):773.
  • 8Lee H, Jang I H, Ryu S H, et al. N-terminal site-specific mono-PEGylation[of epidermal growth factor [J]. Pharm Res, 2003, 20(5) :818.
  • 9Caliceti P. Pharmacokinetics of pegylated inteferons: what is misleading[J].Dig Liver Dis, 2004, 36(3) : 334.
  • 10Caliceti P, Veronese F M. Pharmacokinetic and biodistribution properties of poly (ethylene glycol)-protein conjugates [J]. Adv Dru Deiv Rev, 2003, 55(10) : 1 261.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部